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Abstract
            Traditional time and frequency domain heart rate variability (HRV) have cardiac patients 
at risk of mortality post-myocardial infarction.  More recently, non linear HRV has been applied 
to risk stratification of cardiac patients.  In this review we describe studies of non linear HRV 
and outcome in cardiac patients.  We have included studies that used the three most common 
non-linear indices: power law slope, the short term fractal scaling exponent and measures based 
on Poincaré plots.  We suggest that a combination of traditional and non-linear HRV may be 
optimal for risk stratification.  Considerations in using non linear HRV in a clinical setting are 
described.
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            The association between traditional time and frequency domain measures of heart rate 
variability (HRV) and cardiovascular outcomes has been the subject of numerous investigations.  
Although there were earlier reports suggesting the potential clinical importance of HRV, the 
well-known paper published by Kleiger and colleagues reporting the results of the Multi-Center 
Post-Infarction Project (MPIP) in 1987 can be viewed as the beginning of serious interest in 
HRV among cardiologists1.   This paper reported the remarkable independent association of a 
single, time domain HRV measure, SDNN, the standard deviation of all normal-to-normal (NN) 
interbeat intervals over 24-hours and risk of mortality 1-year post-MI.  With the publication of 
this paper, the race was on and investigators tried to determine whether other time domain HRV 
variables were, perhaps better predictors of outcome.  By 1991, frequency domain measures, 
based on the fast Fourier transform or similar mathematical analyses, had been applied to 24-
hour Holter recordings, with seemingly even better results2. Large datasets of Holter recordings 
began to be collected, especially by the group at St. George’s in London who developed their 
own geometric measures of HRV that could be applied to Holter recordings without the 
requirement of painstaking and exacting characterization of all interbeat intervals3.  By the mid-
90’s, there were a number of studies verifying the predictive value of HRV in various cardiac 
patient populations, and the Task Force of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology had issued a set of formal recommendations 
for the measurement and clinical uses of HRV4.
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            At about that time, investigators began to consider whether measures of HRV derived 
from non-linear mathematics might have some application to clinical populations.  It is beyond 
the scope of this review to detail the various methods that were applied.   Rather, we will 
concentrate in detail on the three best-known: the power law slope, measures derived from the 
Poincaré plot and the short-term fractal-scaling exponent.  In the sections below we will discuss 
some of the significant investigations in the field.  Table 1 provides a more complete listing of 
studies in the field.
Power Law Slope
               When HRV is analyzed in the frequency domain, the variance of the signal is 
decomposed into its sinusoidal components at various underlying frequencies.   This can be 
visualized in a plot of the HRV power spectrum (see Figure 1) in which the area under the curve 
at each frequency (on the x-axis in Hz) is equal to the variance explained at that frequency.  In 
1982 Kobayashi and Musha reported on the frequency dependence of the HRV power spectrum a 
normal young man5.   That is, they noted that when the power spectrum is plotted on a log:log 
scale, as in Figure 1, at least below 10-2 Hz, the amount of power increased, linearly, as the 
underlying frequency decreased (called a 1/f relationship).  The slope of this regression line is 
now referred to as the power law slope, and its intercept with the y-axis is the power law 
intercept.  In non-linear terminology, this meant that fractal scaling properties of longer-term 
HRV were self-similar on a scale of minutes to hours.
 
Figure 1.  Log: log plot of the HRV power spectrum over 24 hours. The region between 0.01 
and 0.0001 Hz is used to calculate power law slope.          
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        Table 1.  Studies of Non-Linear HRV in Cardiac Patients
 
            The potential prognostic value of the power law slope was reported in 1996 when Bigger 
and his co-workers re-analyzed data from MPIP6.   In addition, they compared power law slope 
and intercept between N=274 MPIP patients (patients with a recent myocardial infarction), 274 
healthy persons and 19 people with heart transplants.  They concluded that MI caused a relative 
denervation of the heart (steeper slope, decreased intercept) that was significantly more adverse 
among heart transplant patients.  This is illustrated in Figure 2 which compares power law slope 
for a healthy subjects and one with severe cardiac disease.   Individually and especially 
combined, power law regression parameters were stronger predictors of death from any cause or 
arrhythmic death than traditional measures of time or frequency domain HRV. 
            In a subsequent prospective study by Huikuri and his co-workers, N=347 people >65 
years of age were followed for 10 years7.   Power law slope (<-1.50) was the best univariate 
predictor of all cause mortality (odds ratio, 7.9; 95% CI 3.7 to 17.0; p<0.0001).  Decreased 
power law slope predicted both cardiac and cerebrovascular death, suggesting that altered long 
term behaviour of HR reflects an increased risk of vascular causes of death, rather than being a 
marker of any disease or frailty leading to death. 
            Similarly, HRV indices, including power law slope was compared in 2 groups of patients 
after acute myocardial infarction, one with normal and one with reduced ejection fraction.  A 
more negative power law slope was observed in patients with reduced ejection fraction after 
myocardial infarction but not in those with a normal ejection fraction8. This study was small 
(N=35) and no relationship with outcome was reported.
DFA1 (Short-Term Fractal Scaling Exponent)   
            In 1995, CK Peng and colleagues proposed a novel non-linear measure of HRV called the 
short-term fractal scaling exponent9. Unlike many of the other proposed non-linear measures, 
this  new  measure was  relatively  straightforward  to compute and  not  hampered  by  any 
mathematical assumptions.  The mathematical algorithm for calculating the short-term fractal 
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scaling exponent (referred to as DFA1, alpha-1 or α1) can be downloaded from PhysioNet 
(www.PhysioNet.org).  DFA1 has been calculated from all interbeat intervals, regardless of their 
aetiology, and it has been calculated from normal-to-normal interbeat intervals only.  DFA1, 
which can be calculated from a minimum of 1000 beats and then averaged, reflects the amount 
of randomness in the heart rate time series, with the lowest values (~0.5) associated with a 
completely random time series and the highest values (1.5) associated with a time series that is 
totally correlated.   It is becoming clear that increased randomness of heart rate patterns, i.e., a 
high   degree   of   sinus   arrhythmia   of   non-respiratory   origin,   is   associated   with   a   worse 
prognosis10. 
 
Figure 2. Examples of the power law slope in a) a patient with cardiac disease. And b) a healthy 
person. 
            It should be noted that the algorithm for the calculation of DFA1 has recently been 
improved, and although values calculated using the old and new algorithms correlate >0.95, the 
old value for normal DFA1 was a bit over 1 and the new one is about 1.2.  All of the studies 
referred to below use the old algorithm but future studies will increasingly use the newer one.
            In the TRACE (TRAndopril Cardiac Evaluation study) which enrolled 159 patients with 
acute MI and with LV wall motion score <1.2 or LVEF <35%, Holter recordings were obtained 
3.7 days post-MI.  Patients were followed for up to 4 years, at which time 45% had died.  Among 
all analysed variables, reduced short-term fractal scaling exponent (α1<0.85) was the best 
univariable predictor of mortality (relative risk 3.17, 95% CI 1.96-5.15, p<0.0001) with positive 
and negative predictive accuracies of 65% and 86% respectively.  Even after adjustment for 
clinical covariates and LV function, in the Cox proportional hazards analysis, decreased α1 was 
an independent predictor of mortality (p<0.001)11.
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            More recently, α1 was shown to predict mortality in patients with heart failure.  In a sub 
study of the DIAMOND CHF trial which enrolled patients with left ventricular wall motion 
index ≤1.2 (equivalent to ejection fraction 35%), N=499 eligible patients were followed up for 
mean period of 665  374 days, during which time N=210 died.   After adjustment for age, 
functional class, medication and left ventricular ejection fraction in the multivariate proportional 
hazards analysis, decreased α1 predicted mortality (RR=1.4, 95%CI 1.0-1.9, p<0.05). HRV was 
a better predictor of outcome among those with moderate heart failure (Class II) but HRV was 
not an independent predictor of mortality among those with severe heart failure (class III or IV).  
               Recently Laitio and his co-workers12  reported that reduced alpha1 is predictive of 
postoperative myocardial infarction in elderly patients having emergent surgery for traumatic hip 
fracture.  N=32 patients, aged 60, with preoperative nighttime and daytime Holter recordings 
were studied.  The short term fractal scaling exponent of RR intervals was assessed from 2:00 
AM to 5 AM and 7AM to 12 noon for each patient.  Preoperative α1 was significantly lower 
during the nighttime compared with the daytime (0.92±0.08 vs. 1.03±0.06, p=0.002) in patients 
with  postoperative   MI.   Results   suggest  that  preoperatively  decreased  night  time   fractal 
correlation properties of HR dynamics may identify elderly patients at risk for developing 
myocardial   ischemia   in   the   early   postoperative   phase   after   nonvascular   surgery.  
Poincaré Dimension
            The Poincaré plot is a graphic method for representing the underlying structure of the R-
R interval time series.  In a Poincaré plot, also known as a return map plot, the time between 
each pair of beats is plotted against the time between the next pair of beats, i.e., the x, y co-
ordinates of each point are rri, rri+1.  An example is see in Figure 3.  As is the case with the 
short-term fractal scaling exponent, some investigators plot every interbeat interval in the heart 
rate timeseries and others use only the normal-to-normal intervals.  When all R-R intervals are 
plotted, the assumption is made that only the beats in the central portion of the plot are normal 
and that outlier beats are ectopic.  Plots of morphologically normal-to-normal interbeat intervals 
have proved that this assumption is simplistic and misleading.10
            In one of the earliest studies involving Poincaré plots in a cardiac patient population, 
Woo et al13 constructed Poincaré plots of sinus R-R intervals from 24-hour Holter recordings in 
N= 24 healthy control subjects and N=24 patients with heart failure.  In the control group, plots 
had a comet shape resulting from an increase in beat-to-beat dispersion at slower heart rates.  No 
heart failure patient displayed a comet-shaped pattern.  Instead, three distinctive patterns were 
identified: (1) a torpedo shaped pattern resulting from low R-R interval dispersion over the entire 
range of heart rates, 2) a fan-shaped pattern resulting from restriction of overall R-R interval 
ranges with enhanced dispersion and 3) complex pattern with clusters of points characteristic of 
sudden changes in R-R intervals.  Thus, the Poincaré plots revealed a complexity in heart rate 
patterns, which could not be perceived from standard heart rate variability measures like SDNN 
(the standard deviation of all normal-to-normal interbeat intervals).   Indeed SDNN was not 
different in patients with different HR patterns.  However, serum norepinephrine levels were 
significantly higher among heart failure patients with complex Poincaré plots, suggesting that 
these plots are a marker for increased sympathetic activation and might provide additional 
prognostic information and insight into autonomic alterations in patients with heart failure14.  
Quantification of Poincaré Plots
            We previously alluded to the presence of increased randomness in heart rate patterns and 
their potential as a marker of increased risk.  As can be appreciated from Figure 3, because each 
point on the plot represent the relationship of one beat to the next, increased randomness of heart 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 5(3): 210-220 (2005)Phyllis K. Stein, Anand Reddy,                                                                                              215  
“Non-Linear Heart Rate Variability and Risk Stratification in Cardiovascular Disease” 
rate patterns can easily be recognized in the Poincaré plot as well.  Figure 4 shows examples of 
normal and abnormal heart rate patterns seen on hourly Poincaré plots.  These plots illustrate that 
an increased dispersion of points results in an increase in the relative width of the plot compared
 
Figure 3.  Example of a Poincaré plot showing the calculation of SD1 and SD2 from an ellipse 
fitted to the plot.
with its length.  The non-linear index SD12 quantifies the shape of the Poincaré plot. SD12 is the 
ratio of the lengths of the axes of an imaginary ellipse which has its center at the average RR (or 
NN) interval of the time series and is fitted to the Poincaré plot.  As shown in Figure 3, the 
longitudinal axis of this ellipse is along a line beginning at the origin and with a slope of 1 and 
has a length called SD2.  SD2 reflects intermediate-term variability.  The length of the transverse 
axis of the ellipse is SD1 and reflects short-term variability.  SD12 is the ratio of these measures. 
            In our lab, HRV from 740 tapes recorded before antiarrhythmic therapy in the Cardiac 
Arrhythmia Suppression Trial was studied15.    CAST was an historic post MI study with 
impaired left ventricular ejection fraction and high grade ventricular arrhythmias that were 
suppressed with one of three antiarrhythmic therapies (encainide, flecainide or moricizine)16.  
Holter recordings were obtained at a large range of times post MI.  Subjects in the HRV substudy 
were patients with ventricular premature contractions (VPCs) suppressed on the first randomised 
antiarrhythmic treatment.   They were 70±121 post MI and follow up was 362±241days (70 
deaths).  Traditional time and frequency domain HRV were determined from the qualifying, pre-
randomization Holter recording.  Non-linear HRV measures included short-term fractal scaling 
exponent and SD12, each calculated from an average of 1000 normal-to-normal interbeat 
intervals and power law slope calculated from the entire recording.  As mentioned, this group of 
patients was at a broad range of times post-MI whereas in the studies discussed earlier HRV was 
measured shortly after MI.  As a result, some patients had undergone CABG surgery between 
their MI and their first Holter recordings.  Decreased HRV among post-CABG patients is caused 
by the surgery itself and has been shown to be of no prognostic value.  Therefore, post-CABG 
patients were excluded from the analysis17. Similarly, in the CAST population, the decreased 
HRV associated with diabetes was not prognostic.  Thus, when the analysis was limited to those 
without CABG surgery post-MI or diabetes, power law slope had no association with mortality.  
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A significant association was seen for DFA1 (p<0.001).   However, increased SD12 had the 
strongest association with mortality.   Importantly, however, in this study, we showed that 
traditional time and frequency domain HRV and non-linear HRV were independent predictors of 
mortality.   That   is,   when   all   clinical   and   demographic   covariates   were   considered,   the 
combination of increased SD12 (<55%), decreased ultra low frequency power (a measure of the 
circadian rhythm of HR), history of prior MI and history of CHF identified the patients at highest 
risk of mortality.
 
Figure 4.  Representative one hour Poincaré plots. Figures 4a) and 4c) show normal HRV 
patterns.  Figures 4b) and 4d) show abnormal, complex HRV patterns.
               We also determined the predictive value of DFA1 in association with traditional 
frequency domain HRV in the Cardiovascular Health Study, a prospective, population-based 
study of risk factors for heart disease and stroke among community-dwelling adults aged >65 
year18. Of these participants, 1227 had 24-hour recordings eligible for frequency domain and 
non-linear analysis that were obtained at the beginning of the study.   After 8 years of follow up, 
267 had died.   On univariate analysis, decreased values for all frequency domain HRV indices 
except for high frequency power (HF, a measure of the power of vagally-modulated respiratory 
sinus arrhythmia), and also decreased DFA1, were significantly associated with mortality.   
When HRV indices were combined, even after adjustment for age, gender, presence of 
subclinical or clinical cardiovascular disease and diabetes, the combination of decreased DFA1 
and decreased HF was the strongest predictors of mortality.   In the adjusted model, the risk ratio 
for DFA1 was 0.15 (95% CI 0.08-0.29) and for (ln) HF it was 0.78 (95% CI 0.069-0.88) all 
p<0.001.   We hypothesize that HF power is significantly exaggerated by sinus arrhythmia of 
non-respiratory origins, thus eliminating its association with mortality.  However, when DFA1 is 
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added to the model, it essentially controls for this randomness, permitting the association of 
decreased vagal modulation of HR and mortality to be determined.
Practical Considerations
            Both increased SD12 and decreased DFA1 reflect increased randomness in the heart rate 
time series and are therefore highly correlated.  As mentioned, DFA1 is dependent on accurate 
Holter scanning, but SD12 is less sensitive to scanning error.  This might help explain its better 
prognostic value in the CAST study, mentioned above; where Holters were scanned on older 
equipment where accurate labelling of each beat would have taken days in some cases.  Also, 
Poincaré plots can be examined visually and additional insights gained from their structure.   
While most studies that have used Poincaré plots examined patterns from 24-hour recordings, 
24-hours of data represents >100,000 beats and details patterns may be obscured by looking only 
at the entire recording.  In our lab, we examine hourly Poincaré plots and have noted that periods 
of increased randomness of HR patterns can occur in recordings that have many hours of normal 
patterns.   Finally, power law slope, because it is based on a regression line, is relatively 
insensitive to scanning errors, but its prognostic value has not been as consistently verified.
Caveats and Conclusions
            It is clear that non-linear HRV analysis has the potential to substantially improve the 
utility of HRV for risk stratification.   The circumstances under which non-linear HRV is 
applicable have not been fully elucidated.  Non-linear HRV is not available from commercial 
Holter scanning systems, but most export an annotated beat-to-beat file that, with a little bit of 
computer expertise, can be used to generate non-linear HRV indices.  Considerable care must be 
taken to accurately label the morphology of each beat.  The Holter scanning system must provide 
a way to ensure that the interbeat intervals reflect a consistent detection of beat onset at the same 
point of each QRS, or a least of each series of QRS.  Unfortunately, at the moment this is often 
not the case.  Filters that automatically label beats by prematurity are not sufficient to insure 
accurate enough scanning, certainly for calculation of DFA1, at least when it is based on normal-
to-normal interbeat intervals.   Computer technology is advancing rapidly.   The need to risk-
stratify patients for implantable cardiac defibrillators has enlivened the search for Holter-based 
risk markers of increased risk.  Because of these factors, it is likely that future Holter scanners 
will have far more sensitive beat-detection and beat classification algorithms, making it possible 
to obtain sufficiently accurate scanning to permit routine calculation of non-linear HRV for risk 
stratification in the clinical setting. 
Glossary of Abbreviations 
Alpha-1 (α1)=short-term fractal scaling exponent, a non-linear measure of the randomness or 
correlatedness of heart rate patterns
CABG  =  coronary artery bypass grafting
DFA1 = same as alpha-1.
HRV = heart rate variability.
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SDNN = standard deviation of all normal-to-normal interbeat intervals in ms, a traditional 
measure of heart rate variability.
SD1 =  short axis of ellipse fitted around a Poincaré plot of N-N intervals in ms 
SD2  =  long axis of an ellipse fitted around a Poincaré plot of N-N intervals in ms 
SD12  =  SD1/SD2
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